• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Crypto Market: Growth Opportunities for USUAL Amid Bitcoin Surge

user avatar

by Giorgi Kostiuk

a year ago


As the new week begins, there's noticeable upside momentum among altcoins, driven by Bitcoin's steady climb towards the $100K mark. Spotlight is on USUAL, demonstrating a rebound after correction.

Market Starts Week with Optimism

Boosted by Bitcoin's rise over 1% in the past 24 hours, altcoins show positive momentum. Notably, USUAL, the native token of Usual, stands out with its recovery following a downturn.

Breakout Potential for USUAL

Since its November listing, USUAL has shown impressive performance, surging over 600% and reaching a peak of $1.65. The token has since entered a correction phase, forming a symmetrical triangle on the 4-hour chart, indicating potential for breakout. Currently trading at $1.012, USUAL is near the triangle's upper resistance-line. Overcoming the $1.08 resistance could pave the way for further gains. Key targets after a successful breakout include $1.44 and $1.65, representing a potential 62% rally from the current price.

Conclusion

USUAL's current price action and technical setup make it a token to watch. A confirmed breakout above resistance could provide significant upside potential, while failure could lead to consolidation or retesting lower support levels.

Opportunities for USUAL growth amid market optimism make it significant for investor assessment. Current technical conditions indicate potential prospects.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Disney's $1 Billion Investment in OpenAI Marks a New Era in Entertainment

chest

The Walt Disney Company has announced a groundbreaking $1 billion equity investment in OpenAI, marking a significant partnership to enhance AI-driven storytelling in entertainment.

user avatarElias Mukuru

Rezolute, Inc. Shares Plummet 90% Following Disappointing Clinical Trial Results

chest

Rezolute, Inc. shares dropped 90% after disappointing Phase 3 clinical trial results for the therapy ersodetug.

user avatarDiego Alvarez

Rezolute Plans FDA Discussions Despite Clinical Trial Setback

chest

Rezolute plans to meet with the FDA to discuss next steps for ersodetug development following disappointing Phase 3 trial results.

user avatarKenji Takahashi

Nexo Faces Regulatory Challenges in South America

chest

Nexo must navigate complex regulatory landscapes in South America to establish its services.

user avatarMiguel Rodriguez

Nexo Acquires Buenbit to Expand in South America

chest

Nexo has acquired Argentine fintech Buenbit, marking a significant expansion into the South American crypto market.

user avatarGustavo Mendoza

Matthew Perry Remains Confident in JasmyCoin's Long-Term Potential

chest

Matthew Perry remains confident in JasmyCoin's long-term potential despite recent price drops.

user avatarRajesh Kumar

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.